"Aminoacridines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
| Descriptor ID |
D000609
|
| MeSH Number(s) |
D03.633.300.046.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminoacridines".
Below are MeSH descriptors whose meaning is more specific than "Aminoacridines".
This graph shows the total number of publications written about "Aminoacridines" by people in this website by year, and whether "Aminoacridines" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Aminoacridines" by people in Profiles.
-
Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia. Cancer Res. 1986 Jul; 46(7):3330-3.
-
Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am J Med. 1986 May; 80(5):789-97.
-
Proliferation dependence of topoisomerase II mediated drug action. Biochemistry. 1986 Apr 22; 25(8):2248-56.
-
Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Cancer Res. 1986 Apr; 46(4 Pt 2):1934-8.
-
Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res. 1986 Apr; 46(4 Pt 2):1939-42.
-
The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). Biochem Biophys Res Commun. 1986 Jan 29; 134(2):638-45.
-
The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivo. Med Oncol Tumor Pharmacother. 1986; 3(2):87-94.
-
Phase II study of AMSA and doxorubicin to treat metastatic breast cancer. Oncology. 1986; 43(4):205-7.
-
QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine. Cancer Treat Rep. 1984 Jul-Aug; 68(7-8):1043-4.
-
Prediction of complete remission in patients with refractory acute leukemia treated with AMSA. J Clin Oncol. 1984 Feb; 2(2):102-6.